More people die due to Cancer than Malaria in Africa what can biotech do to prevent this. -biotech.vision

More people die due to Cancer than Malaria in Africa what can biotech do to prevent this.

Cancer is deadlier than malaria in Africa. In 2015, malaria killed 394,000 Africans, while cancer killed…

Continue Reading
Biotech Researchers discover A new tool to Remove Immune cells from Cancer tumors. -biotech.vision

Biotech Researchers discover A new tool to Remove Immune cells from Cancer tumors.

A new light of hope in the darkness of cancer has arrived. Northwestern University researchers have…

Continue Reading
What makes us human? -biotech.vision

What makes us human?

Human DNA is similar to that of chimpanzees, which are our closest relatives in the process…

Continue Reading
After layoffs, BridgeBio turns to dealmaking for up to 6 drugs -biotech.vision

After layoffs, BridgeBio turns to dealmaking for up to 6 drugs

After a clinical flop and two recent retirements, BridgeBio Pharma plans to fire six of its…

Continue Reading
VistaGen says regulators couldn’t sniff out the abuse potential of its nasal spray for social anxiety -biotech.vision

VistaGen says regulators couldn’t sniff out the abuse potential of its nasal spray for social anxiety

VistaGen Therapeutics will launch its nasal spray for social anxiety after the FDA said it did…

Continue Reading
The COVID-19 pandemic has swept the globe, yet many people still do not understand how it affects the body -biotech.vision

The COVID-19 pandemic has swept the globe, yet many people still do not understand how it affects the body

The COVID-19 pandemic has swept the globe, yet many people still do not understand how it…

Continue Reading
AstraZeneca deepens digital ties with Huma in pursuit of clinical trial apps -biotech.vision

AstraZeneca deepens digital ties with Huma in pursuit of clinical trial apps

To bring digital pressure to its clinical trials, AstraZeneca has strengthened its relationship with software developer…

Continue Reading
Another Eylea rival struggles in phase 2, this time fielded by Ribomic -biotech.vision

Another Eylea rival struggles in phase 2, this time fielded by Ribomic

Another attempt to fight Regeneron and Bayer giant Eylea is struggling in the clinic. This time…

Continue Reading